Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Europa Azucena Gonzalez"'
Autor:
Lorenza Pérez Amill, Mercedes Armand Ugon, Sergio Peña Pérez, Maria Val Casals, Claudio Santos, Gerard Frigola, José Ramon Álamo, Francesca Guijarro, Alfredo Minguela, Àlex Bataller, Juan Gonzalo Correa Saldarriaga, Berta Casanovas Albertí, Mireia Uribe Herranz, Europa Azucena Gonzalez, Daniel Benitez-Ribas, Diego Sanchez, Nestor Tirado, Paola Romecin, Talía Velasco, Pablo Menendez, Antonio Martínez, Montserrat Rovira Tarrats, Jordi Esteve, Avaro Urbano Ispizua, Julio Delgado, Manel Juan, Nela Klein González
Publikováno v:
HemaSphere, Vol 7, p e29611a0 (2023)
Externí odkaz:
https://doaj.org/article/071fe08eee104e288eb493ce7a142c4c
Autor:
Ana Esteve-Solé, Àngela Deyà-Martínez, Irene Teixidó, Elena Ricart, Macarena Gompertz, Maria Torradeflot, Noemí de Moner, Europa Azucena Gonzalez, Ana Maria Plaza-Martin, Jordi Yagüe, Manel Juan, Laia Alsina
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
BackgroundAlthough anti-TNF-α monoclonal antibodies are considered safe during pregnancy, there are no studies on the development of the exposed-infant immune system. The objective was to study for the first time the impact of throughout pregnancy e
Externí odkaz:
https://doaj.org/article/22bf966b1cdf44c5b65b23823607c469
Autor:
Nuria Chic, Eva Ciruelos, Cristina Saura, Europa-Azucena Gonzalez, Luís Álvarez-Vallina, Juan José Lasarte, Alena Gros, Lorea Villanueva, Jordi Canes, Laura Angelats, Aleix Prat, Tomás Pascual, Marta Santisteban, Manel Juan
Publikováno v:
Cancer Research. 83:OT2-10
Background Metastatic triple-negative breast cancer (mTNBC) exhibits a particularly poor clinical outcome, generally with rapid progression and worse overall survival (OS) than other BC subtypes. Among the few therapeutic options, chemotherapy-based
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lucia Mazzotti, Anna Gaimari, Sara Bravaccini, Roberta Maltoni, Claudio Cerchione, Manel Juan, Europa Azucena-Gonzalez Navarro, Anna Pasetto, Daniela Nascimento Silva, Valentina Ancarani, Vittorio Sambri, Luana Calabrò, Giovanni Martinelli, Massimiliano Mazza
Publikováno v:
International Journal of Molecular Sciences. 23:8590
The immune system is a dynamic feature of each individual and a footprint of our unique internal and external exposures. Indeed, the type and level of exposure to physical and biological agents shape the development and behavior of this complex and d
Autor:
Natalia Egri, Hugo Calderón, Robert Martinez, Mario Vazquez, Verónica Gómez-Caverzaschi, Mariona Pascal, Olga Araújo, Manel Juan, Europa Azucena González-Navarro, José Hernández-Rodríguez
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundHumoral and cellular immune responses are known to be crucial for patients to recover from COVID-19 and to protect them against SARS-CoV-2 reinfection once infected or vaccinated.ObjectivesThis study aimed to investigate humoral and T cell
Externí odkaz:
https://doaj.org/article/fba262c9ad9740ea9f5441e5d4ea4dfc
Autor:
Ana García-García, Claudia Fortuny, Victoria Fumadó, Iolanda Jordan, Laura Ruiz-López, Europa Azucena González-Navarro, Natalia Egri, Ana Esteve-Solé, Yiyi Luo, Alexandru Vlagea, Manel Monsonís Cabedo, Cristian Launes, Aleix Soler, Anna Codina, Manel Juan, Mariona Pascal, Angela Deyà-Martínez, Laia Alsina
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
PurposeTo describe SARS-CoV-2 infection outcome in unvaccinated children and young adults with inborn errors of immunity (IEI) and to compare their specific acute and long-term immune responses with a sex-, age-, and severity-matched healthy populati
Externí odkaz:
https://doaj.org/article/89571c6eaf904d93b09b9c7326300166
Autor:
Natalia Egri, Victoria Olivé, José Hernández-Rodríguez, Pedro Castro, Catherine De Guzman, Libertad Heredia, Ana Castellet Segura, M. Dolores Fernandez, Noemi de Moner, María Torradeflot, Judit Ballús, Robert Martinez, Mario Vazquez, Marta Vidal Costa, Carlota Dobaño, Massimiliano Mazza, Lucia Mazzotti, Mariona Pascal, Manel Juan, Europa Azucena González-Navarro, Hugo Calderón
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Cellular and humoral immune responses are essential for COVID-19 recovery and protection against SARS-CoV-2 reinfection. To date, the evaluation of SARS-CoV-2 immune protection has mainly focused on antibody detection, generally disregarding the cell
Externí odkaz:
https://doaj.org/article/e812613cd0b24345b15370c06f4a4ac4
Autor:
Maria Castella, Anna Boronat, Raquel Martín-Ibáñez, Vanina Rodríguez, Guillermo Suñé, Miguel Caballero, Berta Marzal, Lorena Pérez-Amill, Beatriz Martín-Antonio, Julio Castaño, Clara Bueno, Olga Balagué, Europa Azucena González-Navarro, Carles Serra-Pages, Pablo Engel, Ramon Vilella, Daniel Benitez-Ribas, Valentín Ortiz-Maldonado, Joan Cid, Jaime Tabera, Josep M. Canals, Miquel Lozano, Tycho Baumann, Anna Vilarrodona, Esteve Trias, Elías Campo, Pablo Menendez, Álvaro Urbano-Ispizua, Jordi Yagüe, Patricia Pérez-Galán, Susana Rives, Julio Delgado, Manel Juan
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 12, Iss , Pp 134-144 (2019)
Genetically modifying autologous T cells to express an anti-CD19 chimeric antigen receptor (CAR) has shown impressive response rates for the treatment of CD19+ B cell malignancies in several clinical trials (CTs). Making this treatment available to o
Externí odkaz:
https://doaj.org/article/0991d78034c649d5800886f6bf312afe
Autor:
Maria Castella, Miguel Caballero-Baños, Valentín Ortiz-Maldonado, Europa Azucena González-Navarro, Guillermo Suñé, Asier Antoñana-Vidósola, Anna Boronat, Berta Marzal, Lucía Millán, Beatriz Martín-Antonio, Joan Cid, Miquel Lozano, Enric García, Jaime Tabera, Esteve Trias, Unai Perpiña, Josep Ma Canals, Tycho Baumann, Daniel Benítez-Ribas, Elías Campo, Jordi Yagüe, Álvaro Urbano-Ispizua, Susana Rives, Julio Delgado, Manel Juan
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Development of semi-automated devices that can reduce the hands-on time and standardize the production of clinical-grade CAR T-cells, such as CliniMACS Prodigy from Miltenyi, is key to facilitate the development of CAR T-cell therapies, especially in
Externí odkaz:
https://doaj.org/article/c4affb1899c8444da99e673d6cca6b80